Keyword Analysis & Research: structure therapeutics


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
structure therapeutics0.40.8999710022
structure1.180.986849
therapeutics0.120.239892312

Keyword Research: People who searched structure therapeutics also searched

Keyword CPC PCC Volume Score
structure therapeutics0.920.6739340
structure therapeutics stock1.740.1914036
structure therapeutics stock price1.770.5756112
structure therapeutics ipo1.230.5215081
structure therapeutics news1.670.3574270
structure therapeutics market cap1.870.8243141
structure therapeutics share price1.480.8901951
structure therapeutics acquisition0.950.22106
structure therapeutics pipeline0.741413927
structure therapeutics s-10.230.4545377
structure therapeutics nasdaq0.190.6318874
structure therapeutics cnbc0.81911086
structure therapeutics logo0.220.3533028
structure therapeutics inc1.860.6550622
the therapeutic community social structure1.570.886480
gpcr structure therapeutics1.460.6112131

Search Results related to structure therapeutics on Search Engine

  • Structure Therapeutics | World Class Medicines. By Design.

    structuretx.com

    https://structuretx.com/

    WEBStructure’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry and data integration to develop differentiated medicines. Empowered with this technology, our goal is to develop oral small molecule drugs that can deliver biologic-like activity and specificity while overcoming current ...

    DA: 16 PA: 44 MOZ Rank: 5

  • About Us | Structure Therapeutics

    structuretx.com

    https://structuretx.com/about/

    WEBJun 16, 2022 · Harnessing structure-based drug design, coupled with our advanced computational technologies and world-class expertise, we are committed to converting biologics and peptides into life-changing small molecule medicines for everyone around the world. Our Team. Global solutions require global expertise.

    DA: 52 PA: 47 MOZ Rank: 91

  • Pipeline | Structure Therapeutics

    structuretx.com

    https://structuretx.com/pipeline/

    WEBWe are advancing our clinical-stage pipeline of differentiated treatments focused on chronic diseases with high unmet need around the globe, including cardiovascular, metabolic and pulmonary conditions.

    DA: 69 PA: 1 MOZ Rank: 44

  • Structure Therapeutics | Investors & Media

    structuretx.com

    https://ir.structuretx.com/

    WEBStructure Therapeutics is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. By leveraging its next generation structure-based drug discovery platform, the company has built a pipeline including two clinical-stage small ...

    DA: 10 PA: 72 MOZ Rank: 1

  • Structure Therapeutics Reports Fourth Quarter and Full Year …

    structuretx.com

    https://ir.structuretx.com/news-releases/news-release-details/structure-therapeutics-reports-fourth-quarter-and-full-year-2023

    WEBSAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023, …

    DA: 61 PA: 12 MOZ Rank: 16

  • Technology | Structure Therapeutics

    structuretx.com

    https://structuretx.com/technology/

    WEBThe Structure solution. With an unparalleled track record in GPCR structure-based drug design, Structure’s team expertly deploys breakthrough technical advances to navigate these challenges in pursuit of innovative small molecule drugs.

    DA: 90 PA: 6 MOZ Rank: 1

  • Press Releases | Structure Therapeutics

    structuretx.com

    https://ir.structuretx.com/press-releases

    WEBSAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced that Raymond Stevens, Ph.D., the Company’s.

    DA: 21 PA: 64 MOZ Rank: 80

  • News | Structure Therapeutics

    structuretx.com

    https://structuretx.com/news/

    WEBJun 16, 2022 · News | Structure Therapeutics. Catch up on our latest press releases, corporate updates and announcements. Press Releases. ALL. 2023. 2022. 2021. Structure Based Discovery and Anti-fibrotic Activity of Novel Antagonists of Lysophosphatidic Acid Receptor 1 (LPAR1) (Presented at ATS 2023) May 27, 2023.

    DA: 66 PA: 17 MOZ Rank: 13

  • Structure Therapeutics Announces Positive Results from Phase …

    yahoo.com

    https://finance.yahoo.com/news/structure-therapeutics-announces-positive-results-113000749.html

    WEBSAN FRANCISCO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule...

    DA: 93 PA: 57 MOZ Rank: 52

  • Structure Therapeutics Announces Positive Results from Phase …

    structuretx.com

    https://ir.structuretx.com/news-releases/news-release-details/structure-therapeutics-announces-positive-results-phase-1b

    WEBSep 29, 2023 · Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update | Structure Therapeutics. September 29, 2023. PDF Version. GSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b …

    DA: 65 PA: 26 MOZ Rank: 24